| Home | E-Submission | Sitemap | Editorial Office |  
top_img
    
REVIEW
Pathologic differential diagnosis of metastatic carcinoma in the liver
The liver is one of the most common sites to which malignancies preferentially metastasize. Although a substantial number of liver malignancies are primary tumors, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma, the metastasis of carcinomas to the liver i...
REVIEW
Radiomics and radiogenomics of primary liver cancers
Concurrent advancements in imaging and genomic biomarkers have created opportunities to identify non-invasive imaging surrogates of molecular phenotypes. In order to develop such imaging surrogates radiomics and radiogenomics/imaging genomics will be necessary; there has been co...
ORIGINAL ARTICLE
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Background/Aims: An estimated 80 million people worldwide are infected with viremic hepatitis C virus (HCV). Even after eradication of HCV with direct acting antivirals (DAAs), hepatic fibrosis remains a risk factor for hepatocarcinogenesis. Recently, we confirmed the applicabil...
ORIGINAL ARTICLE
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
Background/Aims: Nonalcoholic fatty liver disease (NAFLD) is becoming a worldwide epidemic, and is frequently found in patients with chronic hepatitis B (CHB). We investigated the impact of histologically proven hepatic steatosis on the risk for hepatocellular carcinoma (HCC) in...
Current Issue
Volume 25(1); Mar 2019
Volume 24(4); December 2018
Volume 24(3); September 2018
Volume 24(2); June 2018
Volume 24(1); March 2018
RSS feed
Reviews
1 Recent research trends and updates on nonalcoholic fatty liver disease
Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn, On behalf of the Korean Association for the Study of the Liver (KASL)-Korea Nonalcoholic fatty liver Study Group (KNSG)
Clin Mol Hepatol.2019;25(1):1-11.   Published online August 8, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0037
                                 Cited By 2
12 Pathologic differential diagnosis of metastatic carcinoma in the liver
Jeong Hwan Park, Jung Ho Kim
Clin Mol Hepatol.2019;25(1):12-20.   Published online October 5, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0067
                              
21 Radiomics and radiogenomics of primary liver cancers
Woo Kyoung Jeong, Neema Jamshidi, Ely Richard Felker, Steven Satish Raman, David Shinkuo Lu
Clin Mol Hepatol.2019;25(1):21-29.   Published online November 16, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1007
                                 Cited By 1
30 Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti
Clin Mol Hepatol.2019;25(1):30-36.   Published online January 23, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0061
                              
Editorials
37 Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
Young Woo Eom, Soon Koo Baik
Clin Mol Hepatol.2019;25(1):37-39.   Published online December 11, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1011
                              
40 Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on.
Won Kim
Clin Mol Hepatol.2019;25(1):40-41.   Published online December 28, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0101
                              
Original Articles
42 Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht
Clin Mol Hepatol.2019;25(1):42-51.   Published online November 19, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0029
                              Supplementary         Cited By 1
52 Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kwang-il Kim, Soo-Hwan Kim, Kyu Sung Rim, Seong Gyu Hwang
Clin Mol Hepatol.2019;25(1):52-64.   Published online October 23, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0040
                              
65 Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
Shinya Sato, Kei Moriya, Masanori Furukawa, Soichiro Saikawa, Tadashi Namisaki, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Naotaka Shimozato, Yasuhiko Sawada, Kenichiro Seki, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji
Clin Mol Hepatol.2019;25(1):65-73.   Published online February 25, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0070
                              
74 Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Teerha Piratvisuth
Clin Mol Hepatol.2019;25(1):74-85.   Published online February 28, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0072
                              
Letter to the Editor
86 Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation
Karina Lucio de Medeiros Bastos, Caio Robledo Quaio, Fabiana Roberto Lima, Iana Manuelle Araújo, Candice Alves Tavares Araújo, Flávia Balbo Piazzon, Ismael Dale Cotrim Guerreiro da Silva, Gabriel Nuncio Benevides, Ana Cristina Tannuri, Uenis Tannuri, Ramiro Anthero Azevedo, Chong Ae Kim
Clin Mol Hepatol.2019;25(1):86-91.   Published online August 28, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0005
                              Supplementary         Cited By 1
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 302
TOTAL : 113194